Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Listerine is a brand of antiseptic mouthwash products, most notably the original Listerine Antiseptic formulation. It contains a specific combination of four essential oils: eucalyptol, menthol, methyl salicylate, and thymol. The mechanism of action involves the non-selective disruption of bacterial cell membranes and the inhibition of bacterial enzymes, which effectively reduces the bacterial load in the oral cavity and penetrates dental biofilms. It is primarily indicated for the prevention and reduction of plaque and gingivitis, as well as the treatment of halitosis. Originally developed by Joseph Lawrence and Jordan Wheat Lambert in 1879 as a surgical antiseptic, it is currently owned and manufactured by Kenvue, a consumer health company spun off from Johnson & Johnson.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Listerine.